Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00423722 · ClinicalTrials.gov registry record · NA
Parenteral Hydration in Advanced Cancer Patients
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 262
- Enrollment target
NCT00423722: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00423722 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 262 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00423722, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn whether being hydrated (given liquids) through a catheter in a vein or in the tissue under the skin can improve symptoms of dehydration. Objectives: 1.1 Determine whether parenteral hydration is superior to placebo in improving symptoms associated with dehydration (such as fatigue, myoclonus, sedation, and hallucinations) in advanced cancer patients receiving hospice care. 1.2 Determine whether parenteral hydration is superior to placebo in delaying the onset or reducing the severity of delirium in patients with advanced cancer receiving hospice care. 1.3 Describe the meaning patients and primary caregivers attribute to dehydration and re-hydration at the end of patient's lives.
Interventions
- DRUG Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2007-01-09 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00423722
The ClinicalTrials.gov registry entry for NCT00423722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Saline is the first listed.
NCT00423722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00423722 about?
NCT00423722 is a clinical study titled "Parenteral Hydration in Advanced Cancer Patients". The goal of this clinical research study is to learn whether being hydrated (given liquids) through a catheter in a vein or in the tissue under the skin can improve symptoms of dehydration. Objectives: 1.1 Determine whether parenteral hydration is superior to placebo in improving symptoms associat...
What is the current status of trial NCT00423722?
This trial is currently completed. It is a NA study. The enrollment target is 262 participants. The study started on 2007-01-09. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00423722?
The interventions under investigation include: Saline (DRUG).
Who is sponsoring clinical trial NCT00423722?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.